Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
NCT ID: NCT01127750
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
2417 participants
INTERVENTIONAL
2010-05-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
NCT01201356
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
NCT00537082
An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis
NCT00670449
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis
NCT00333138
A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720
NCT01578330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FTY720
FTY720
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FTY720
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with history of chronic immune disease
* Patients with a history of certain cancers
* Diabetic patients with certain eye disorders
* Patients who are on certain immunosuppressive medications or heart medications
* Patients with certain heart conditions
* Patients with certain lung conditions
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Investigative Site
Box Hill, , Australia
Novartis Investigative Site
Heidelberg, , Australia
Novartis Investigative Site
Kogarah, , Australia
Novartis Investigative Site
Liverpool, , Australia
Novartis Investigative Site
Woodville South, , Australia
Novartis Investigational Site
Linz, , Austria
Novartis Investigational Site
Vienna, , Austria
Novartis Investigational Site
Vienna, , Austria
Novartis Investigational Site
Bruges, , Belgium
Novartis Investigational Site
Brussels, , Belgium
Novartis Investigational Site
Brussels, , Belgium
Novartis Investigational Site
Charleroi, , Belgium
Novartis Investigational Site
Leuven, , Belgium
Novartis Investigational Site
Melsbroek, , Belgium
Novartis Investigational Site
Overpelt, , Belgium
Novartis Investigational Site
Sijsele, , Belgium
Novartis Investigational Site
Tinlot, , Belgium
Novartis Investigational Site
Wilrijk, , Belgium
Novartis Investigational Site
Montreal, , Canada
Novartis Investigational Site
Québec, , Canada
Novartis Investigational Site
Victoria, , Canada
Novartis Investigational Site
Prague, , Czechia
Novartis Investigational Site
Teplice, , Czechia
Novartis Investigational Site
Aarhus, , Denmark
Novartis Investigational Site
Copenhagen, , Denmark
Novartis Investigational Site
Helsinki, , Finland
Novartis Investigational Site
Turku, , Finland
Novartis Investigational Site
Aachen, , Germany
Novartis Investigative Site
Aachen, , Germany
Novartis Investigational Site
Aalen, , Germany
Novartis Investigational Site
Abensberg, , Germany
Novartis Investigational Site
Achim, , Germany
Novartis Investigational Site
Alzenau in Unterfranken, , Germany
Novartis Investigational Site
Aschaffenburg, , Germany
Novartis Investigational Site
Attenberg, , Germany
Novartis Investigational Site
Augsburg, , Germany
Novartis Investigational Site
Bad Honnef, , Germany
Novartis Investigational Site
Bad Krozingen, , Germany
Novartis Investigative Site
Bad Mergentheim, , Germany
Novartis Investigational Site
Bad Neustadt / Saale, , Germany
Novartis Investigational Site
Bamberg, , Germany
Novartis Investigational Site
Bamberg, , Germany
Novartis Investigative Site
Bayreuth, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novarris Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Bielefeld, , Germany
Novartis Investigative Site
Bielefeld, , Germany
Novartis Investigative Site
Bielefeld, , Germany
Novartis Investigational Site
Bochum, , Germany
Novartis Investigative Site
Bochum, , Germany
Novartis Investigational Site
Bochum, , Germany
Novaratis Investigative Site
Bochum, , Germany
Novartis Investigational Site
Bogen, , Germany
Novartis Investigative Site
Bonn, , Germany
Novartis Investigative Site
Bonn, , Germany
Novartis Investigative Site
Böblingen, , Germany
Novartis Investigational Site
Braunschweig, , Germany
Novartis Investigational Site
Buchholz, , Germany
Novartis Investigational Site
Chemnitz, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigational Site
Dillingen, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Düsseldorf, , Germany
Novartis Investigational Site
Eisenach, , Germany
Novartis Investigative Site
Emden, , Germany
Novartis Investigational Site
Emmendingen, , Germany
Novartis Investigative Site
Erbach im Odenwald, , Germany
Novartis Investigational Site
Erfurt, , Germany
Novartis Investigational Site
Erlangen, , Germany
Novartis Investigative Site
Essen, , Germany
Novartis Investigational Site
Essen, , Germany
Novartis Investigative Site
Essen, , Germany
Novartis Investigational Site
Frankfurt, , Germany
Novartis Investigational Site
Frankfurt, , Germany
Novartis Investigative Site
Freiburg im Breisgau, , Germany
Novartis Investigational Site
Greifswald, , Germany
Novartis Investigational Site
Grevenbroich, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigational Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigational Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Hanover, , Germany
Novartis Investigative Site
Heidelberg, , Germany
Novartis Investigational Site
Herborn, , Germany
Novartis Investigational Site
Herdecke, , Germany
Novartis Investigational Site
Herne, , Germany
Novartis Investigational Site
Homburg, , Germany
Novartis Investigational Site
Itzehoe, , Germany
Novartis Investigational Site
Jena, , Germany
Novartis Investigational Site
Jena, , Germany
Novartis Investigational Site
Kaltenkirchen, , Germany
Novartis Investigative Site
Kandel, , Germany
Novartis Investigational Site
Karlsruhe, , Germany
Novartis Investigational Site
Karlstadt am Main, , Germany
Novartis Investigational Site
Kassel, , Germany
Neuroscience Research of the Berkshires
Krefeld, , Germany
Novartis Investigational Site
Landshut, , Germany
Novartis Investigational Site
Lappersdorf, , Germany
Novartis Investigational Site
Leipzig, , Germany
Novartis Investigative Site
Lengerich, , Germany
Novartis Investigational Site
Lohr a. Main, , Germany
Novartis Investigational Site
Ludwigshafen, , Germany
Novartis Investigative Site
Ludwigshafen, , Germany
Novartis Investigative Site
Magdeburg, , Germany
Novartis Investigative Site
Mainz, , Germany
Novartis Investigational Site
Mannheim, , Germany
Novartis Investigational Site
Marburg, , Germany
Novartis Investigational Site
Marburg, , Germany
Novartis Investigational Site
Mittweida, , Germany
Novartis Investigational Site
Mönchengladbach, , Germany
Novartis Investigational Site
München, , Germany
Novartis Investigational Site
München, , Germany
Novartis Investigational Site
München, , Germany
Novartis Investigational Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigational Site
München, , Germany
Novartis Investigational Site
Münster, , Germany
Novartis Investigational Site
Nagold, , Germany
Novartis Investigational Site
Neu-Ulm, , Germany
Novartis Investigational Site
Neuburg am Inn, , Germany
Novartis Investigational Site
Neuruppin, , Germany
Novartis Investigational Site
Nuremberg, , Germany
Novartis Investigative Site
Oldenburg, , Germany
Novartis Investigational Site
Osnabrück, , Germany
Novartis Investigational Site
Ostfildern, , Germany
Novartis Investigational Site
Pforzheim, , Germany
Novartis Investigational Site
Potsdam, , Germany
Novartis Investigational Site
Potsdam, , Germany
Novartis Investigational Site
Prien am Chiemsee, , Germany
Novartis Investigational Site
Regensburg, , Germany
Novartis Investigational Site
Rostock, , Germany
Novartis Investigational Site
Rösrath, , Germany
Novartis Investigative Site
Rudersdorf, , Germany
Novartis Investigational Site
Schwarzenbruck, , Germany
Novartis Investigative Site
Schwendi, , Germany
Novartis Investigative Site
Siegen, , Germany
Novartis Investigational Site
Sigmaringen, , Germany
Novartis Investigational Site
Sinsheim, , Germany
Novartis Investigative Site
Stade, , Germany
Novartis Investigational Site
Stuttgart, , Germany
Novartis Investigative Site
Stuttgart, , Germany
Novartis Investigative Site
Stuttgart, , Germany
Novartis Investigational Site
Stuttgart, , Germany
Novartis Investigational Site
Teupitz, , Germany
Novartis Investigational Site
Tübingen, , Germany
Novartis Investigative Site
Ulm, , Germany
Novartis Investigational Site
Unterhaching, , Germany
Novartis Investigational Site
Wendlingen, , Germany
Novartis Investigational Site
Wermsdorf, , Germany
Novartis Investigational Site
Westerstede, , Germany
Novartis Investigational Site
Wiesbaden, , Germany
Novartis Investigative Site
Wiesbaden, , Germany
Novartis Investigational Site
Wuppertal, , Germany
Novartis Investigational Site
Würzburg, , Germany
Novartis Investigational Site
Alexandroupoli, , Greece
Novartis Investigational Site
Athens, , Greece
Novartis Investigational Site
Athens, , Greece
Novartis Investigational Site
Thessaloniki, , Greece
Novartis Investigational Site
Thessaloniki, , Greece
Novartis Investigational Site
Budapest, , Hungary
Novartis Investigational Site
Budapest, , Hungary
Novartis Investigational Site
Budapest, , Hungary
Novartis Investigational Site
Pécs, , Hungary
Novartis Investigational Site
Szeged, , Hungary
Novartis Investigational Site
Cork, , Ireland
Novartis Investigational Site
Dublin, , Ireland
Novartis Investigative Site
Acquaviva delle Fonti, , Italy
Novartis Investigative SIte
Asti, , Italy
Novartis Investigative Site
Bergamo, , Italy
Novartis Investigative Site
Bologna, , Italy
Novartis Investigative Site
Cagliari, , Italy
Novartis Investigative Site
Catania, , Italy
Novartis Investigational Site
Foggia, , Italy
Novartis Investigative Site
Foggia, , Italy
Novartis Investigative Site
Milan, , Italy
Novartis Investigative Site
Napoli, , Italy
Novartis Investigational Site
Napoli, , Italy
Novartis Investigational Site
Napoli, , Italy
Novartis Investigative Site
Palermo, , Italy
Novartis Investigative Site
Pozzilli, , Italy
Novartis Investigative Site
Ravenna, , Italy
Novartis Investigational Site
Roma, , Italy
Novartis Investigational Site
Roma, , Italy
Novartis Investigational Site
Roma, , Italy
Novartis Investigational Site
Roma, , Italy
Novartis Investigative Site
Siena, , Italy
Novartis Investigative Site
Udine, , Italy
Novartis Investigative Site
Verona, , Italy
Novartis Investigative Site
Vicenza, , Italy
Novartis Investigative Site
Viterbo, , Italy
Novartis Investigational Site
Amsterdam, , Netherlands
Novartis Investigational Site
Amsterdam, , Netherlands
Novartis Investigational Site
Blaricum, , Netherlands
Novartis Investigational Site
Breda, , Netherlands
Novartis Investigational Site
Enschede, , Netherlands
Novartis Investigational Site
Gouda, , Netherlands
Novartis Investigational Site
Tilburg, , Netherlands
Novartis Investigational Site
Lillehammer, , Norway
Novartis Investigational Site
Molde, , Norway
Novartis Investigational Site
Stavanger, , Norway
Novartis Investigational Site
Bydgoszcz, , Poland
Novartis Investigational Site
Katowice, , Poland
Novartis Investigational Site
Lodz, , Poland
Novartis Investigational Site
Amadora, , Portugal
Novartis Investigational Site
Coimbra, , Portugal
Novartis Investigational Site
Lisbon, , Portugal
Novartis Investigational Site
Porto, , Portugal
Novartis Investigational Site
Porto, , Portugal
Novartis Investigational Site
Kazan', , Russia
Novartis Investigational Site
Kazan', , Russia
Novartis Investigational Site
Moscow, , Russia
Novartis Investigational Site
Moscow, , Russia
Novartis Investigational Site
Moscow, , Russia
Novartis Investigational Site
Nizhny Novgorod, , Russia
Novartis Investigational Site
Nizhny Novgorod, , Russia
Novartis Investigational Site
S.-Petersburg, , Russia
Novartis Investigational Site
Saint Petersburg, , Russia
Novartis Investigational Site
Samara, , Russia
Novartis Investigational Site
Smolensk, , Russia
Novartis Investigational Site
Yekaterinburg, , Russia
Novartis Investigational Site
Banská Bystrica, , Slovakia
Novartis Investigational Site
Bratislava, , Slovakia
Novartis Investigational Site
Trnava, , Slovakia
Novartis Investigational Site
Barcelona, , Spain
Novartis Investigational Site
Barcelona, , Spain
Novartis Investigational Site
Donostia / San Sebastian, , Spain
Novartis Investigational Site
El Palmar, , Spain
Novartis Investigational Site
Madrid, , Spain
Novartis Investigational Site
Madrid, , Spain
Novartis Investigational Site
Santa Cruz de Tenerife, , Spain
Novartis Investigational Site
Santiago de Compostela, , Spain
Novartis Investigational Site
Valencia, , Spain
Novartis Investigational Site
Gothenburg, , Sweden
Novartis Investigational Site
Linköping, , Sweden
Novartis Investigational Site
Umeå, , Sweden
Novartis Investigational Site
Aarau, , Switzerland
Novartis Investigational Site
Carouge, , Switzerland
Novartis Investigational Site
Geneva, , Switzerland
Novartis Investigational Site
Lausanne, , Switzerland
Novartis Investigational Site
Lugano, , Switzerland
Novartis Investigational Site
Sankt Gallen, , Switzerland
Novartis Investigational Site
Zurich, , Switzerland
Novartis Investigational Site
Antalya, , Turkey (Türkiye)
Novartis Investigational Site
Gaziantep, , Turkey (Türkiye)
Novartis Investigational Site
Istanbul, , Turkey (Türkiye)
Novartis Investigational Site
Istanbul, , Turkey (Türkiye)
Novartis Investigational Site
Samsun, , Turkey (Türkiye)
Novartis Investigational Site
Trabzon, , Turkey (Türkiye)
Novartis Investigational Site
Birmingham, , United Kingdom
Novartis Investigational Site
Brighton, , United Kingdom
Novartis Investigational Site
Dundee, , United Kingdom
Novartis Investigational Site
Edinburgh, , United Kingdom
Novartis Investigational Site
Essex, , United Kingdom
Novartis Investigational Site
Great Yarmouth, , United Kingdom
Novartis Investigational Site
Headington, , United Kingdom
Novartis Investigational Site
Liverpool, , United Kingdom
Novartis Investigational Site
London, , United Kingdom
Novartis Investigational Site
London, , United Kingdom
Novartis Investigational Site
Middlesbrough, , United Kingdom
Novartis Investigational Site
Newcastle upon Tyne, , United Kingdom
Novartis Investigational Site
Northampton, , United Kingdom
Novartis Investigational Site
Norwick, , United Kingdom
Novartis Investigational Site
Poole, , United Kingdom
Novartis Investigational Site
Salford, , United Kingdom
Novartis Investigational Site
Sheffield, , United Kingdom
Novartis Investigational Site
Stoke-on-Trent, , United Kingdom
Novartis Investigational Site
Swindon, , United Kingdom
Novartis Investigational Site
Truro, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L; FIRST Study Investigators. Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol. 2014 Feb;261(2):267-76. doi: 10.1007/s00415-013-7115-8. Epub 2013 Nov 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-019029-32
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CFTY720D2316
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.